An in vivo selection-derived d-peptide for engineering erythrocyte-binding antigens that promote immune tolerance.

Proceedings of the National Academy of Sciences of the United States of America
A. R. LoftisBradley L. Pentelute

Abstract

When displayed on erythrocytes, peptides and proteins can drive antigen-specific immune tolerance. Here, we investigated a straightforward approach based on erythrocyte binding to promote antigen-specific tolerance to both peptides and proteins. We first identified a robust erythrocyte-binding ligand. A pool of one million fully d-chiral peptides was injected into mice, blood cells were isolated, and ligands enriched on these cells were identified using nano-liquid chromatography-tandem mass spectrometry. One round of selection yielded a murine erythrocyte-binding ligand with an 80 nM apparent dissociation constant, K d We modified an 83-kDa bacterial protein and a peptide antigen derived from ovalbumin (OVA) with the identified erythrocyte-binding ligand. An administration of the engineered bacterial protein led to decreased protein-specific antibodies in mice. Similarly, mice given the engineered OVA-derived peptide had decreased inflammatory anti-OVA CD8+ T cell responses. These findings suggest that our tolerance-induction strategy is applicable to both peptide and protein antigens and that our in vivo selection strategy can be used for de novo discovery of robust erythrocyte-binding ligands.

References

Jun 1, 1991·Kidney International·B A StoosG Fejes-Tóth
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·A ShevchenkoM Mann
Sep 6, 2003·Methods : a Companion to Methods in Enzymology·Matthias EdingerRobert S Negrin
Nov 25, 2003·Analytical Chemistry·Alexey I NesvizhskiiRuedi Aebersold
May 14, 2004·Pharmaceutical Research·Lisa M HigginsDaniel J O'Mahony
Mar 6, 2007·Annual Review of Biochemistry·John A T Young, R John Collier
Sep 14, 2010·Molecular Pharmaceutics·Stephan Kontos, Jeffrey A Hubbell
Jun 24, 2011·Proceedings of the National Academy of Sciences of the United States of America·Irwin ChenDavid R Liu
Mar 20, 2012·Trends in Pharmacological Sciences·Nina SvensenMark Bradley
Dec 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephan KontosJeffrey A Hubbell
Dec 5, 2013·Chemical Reviews·Bethany Powell Gray, Kathlynn C Brown
Mar 13, 2014·Chembiochem : a European Journal of Chemical Biology·Mark D SimonBradley L Pentelute
Nov 26, 2015·Science Advances·Kristen M LorentzJeffrey A Hubbell
May 20, 2016·ACS Applied Materials & Interfaces·Man YingWeiyue Lu
May 24, 2016·Advanced Drug Delivery Reviews·Ruiwu LiuKit S Lam
Jul 1, 2016·Proceedings of the National Academy of Sciences of the United States of America·Shihui LiuStephen H Leppla
Mar 1, 2017·Nature Chemical Biology·Alexander J MijalisBradley L Pentelute
Mar 9, 2017·Proceedings of the National Academy of Sciences of the United States of America·Novalia PisheshaHidde L Ploegh
Feb 26, 2019·Nature Biotechnology·Pau Serra, Pere Santamaria
Mar 20, 2019·Nature Chemical Biology·Fayçal ToutiBradley L Pentelute
Oct 5, 2019·International Journal of Cancer. Journal International Du Cancer·Sherwin JackRuben C Aguilar
Mar 4, 2020·Toxins·Adriana Tomoko NishiyaMaria Lucia Zaidan Dagli
May 6, 2020·Chembiochem : a European Journal of Chemical Biology·Alexander R LoftisBradley L Pentelute
May 30, 2020·Science·N HartrampfB L Pentelute
Jun 25, 2020·Nature Communications·Anthony J QuartararoBradley L Pentelute
Feb 28, 2021·Science Immunology·Elyse A WatkinsJeffrey A Hubbell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.